Llwytho...

Hepatitis C Virus (HCV)–Specific Immune Responses of Long-Term Injection Drug Users Frequently Exposed to HCV

BACKGROUND: Injection drug users (IDUs) who successfully clear hepatitis C virus (HCV) have a reduced risk of developing chronic reinfection, despite their continuing exposure to the virus. To identify immunological correlates for this apparent protection, we studied HCV-specific immune responses in...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Mizukoshi, Eishiro, Eisenbach, Christoph, Edlin, Brian R., Newton, Kimberly P., Raghuraman, Sukanya, Weiler-Normann, Christina, Tobler, Leslie H., Busch, Michael P., Carrington, Mary, McKeating, Jane A., O’Brien, Thomas R., Rehermann, Barbara
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2008
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2699613/
https://ncbi.nlm.nih.gov/pubmed/18505381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/589510
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!